AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics

Expands AAV gene therapy platform from inside the cell for genetic disorders RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2019 -- (Healthcare Sales & Marketing Network) -- Asklepios BioPharmaceutical, Inc. (AskBio), a fully integrated Adeno-Associated Virus... Biopharmaceuticals, Drug Delivery, Acquisitions Asklepios BioPharmaceutical, AskBio, RoverMed BioSciences
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news